Literature DB >> 11251244

Mucoadhesive nanoparticulate systems for peptide drug delivery.

H Takeuchi1, H Yamamoto, Y Kawashima.   

Abstract

This chapter describes the preparation of and methods for evaluating mucoadhesive nanoparticulate systems, including liposomes and polymeric nanoparticles. Mucoadhesive ability is conferred on the particulate systems by coating their surface with mucoadhesive polymers such as chitosan and Carbopol. The feasibility of this surface modification was confirmed by measuring the zeta potential. Several methods of evaluating the mucoadhesive properties of particulate systems have been reported in the literature. We have also developed some novel evaluation procedures including a particle counting method using a Coulter counter for polymer-coated liposomes. The mucoadhesive properties of the polymer-coated liposomes and polymeric nanoparticles were confirmed by means of these mucoadhesion tests. In applying these mucoadhesive nanoparticles to the oral and pulmonary administration of peptide drugs, more effective and prolonged action was observed in comparison with non-coated systems, thereby confirming the usefulness of mucoadhesive nanoparticulate systems for the delivery of peptide drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11251244     DOI: 10.1016/s0169-409x(00)00120-4

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  43 in total

1.  Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration.

Authors:  Vanna Sanna; Nathalie Kirschvink; Pascal Gustin; Elisabetta Gavini; Isabelle Roland; Luc Delattre; Brigitte Evrard
Journal:  AAPS PharmSciTech       Date:  2004-03-10       Impact factor: 3.246

Review 2.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

Review 3.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

4.  Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery.

Authors:  C Prego; M Fabre; D Torres; M J Alonso
Journal:  Pharm Res       Date:  2006-03-16       Impact factor: 4.200

5.  Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles.

Authors:  Chunqiang Guo; Richard A Gemeinhart
Journal:  Eur J Pharm Biopharm       Date:  2008-06-18       Impact factor: 5.571

Review 6.  Novel platforms for oral drug delivery.

Authors:  P Colombo; F Sonvico; G Colombo; R Bettini
Journal:  Pharm Res       Date:  2009-01-09       Impact factor: 4.200

7.  Insulin containing nanocomplexes formed by self-assembly from biodegradable amine-modified poly(vinyl alcohol)-graft-poly(L-lactide): bioavailability and nasal tolerability in rats.

Authors:  Michael Simon; Matthias Wittmar; Thomas Kissel; Thomas Linn
Journal:  Pharm Res       Date:  2005-08-26       Impact factor: 4.200

8.  Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption.

Authors:  Dave A Miller; James C DiNunzio; Wei Yang; James W McGinity; Robert O Williams
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

Review 9.  Progress in antiretroviral drug delivery using nanotechnology.

Authors:  Rama Mallipeddi; Lisa Cencia Rohan
Journal:  Int J Nanomedicine       Date:  2010-08-09

10.  Preparation of gelatin microbeads with a narrow size distribution using microchannel emulsification.

Authors:  Satoshi Iwamoto; Kei Nakagawa; Shinji Sugiura; Mitsutoshi Nakajima
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.